Search Browse Earnings

Fulgent Genetics, Inc.

Nasdaq:FLGT

Services-Medical Laboratories·EL MONTE, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$289.2M

-53.3% YoY

FY 2025

Adj. EBITDA

-$169.4M

-58.6% margin

FY 2025

Net Income

-$167.8M

-58.0% margin

FY 2025

EPS (Diluted)

$0.01

FY 2018

Stock Price

$14.68

+2.2%

2026-03-12

52W Range

$13.46 – $31.04

P/E Ratio

1468.0x

Market Cap

$458.5M

Cash

$97.5M

FY 2025

Total Debt

$2.9M

FY 2025

Net Cash

$94.6M

FY 2025

Enterprise Value

$363.9M

Debt / EBITDA

0.6x

FY 2025

EV / EBITDA

-2.1x

Employees

—